Rett syndrome is caused by mutations of the MECP2 gene located on the X chromosome. Children with Rett initially show typical ...
As RTT patients are mosaic with respect to MeCP2 expression owing to random X-chromosome inactivation, gene therapy-based strategies for treatment of RTT that involve increasing MeCP2 expression ...
Its main cause is mutations of the gene MeCP2, an important controller of neuronal development in the brain. Precisely for being a master controller, it has been difficult to decipher how exactly ...
Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback